As we remain steadfast in our long-range mission of being the voice for the ovarian cancer community and funding life-saving research, we also want to acknowledge the moment we are in now. We know that the isolation required of all of us may be both familiar to those who are undergoing or have gone through … Continued
She has swum in the Amazon, gone ice fishing in the Arctic, traveled the Galapagos, and hang-glided in New Zealand. But the biggest trail Dr. Beth Karlan has blazed throughout her life has been in the field of gynecologic oncology. Dr. Karlan is Professor and Vice Chair of Women’s Health Research in the Department of … Continued
(March 13, 2020) As a global charity, we recognize the extraordinarily stressful times we as a society are all in together. We have taken every precaution to protect OCRA staff as they continue to do their jobs (remotely) in our collective fight against ovarian cancer. And if you have ovarian cancer and are concerned about … Continued
Dr. Ron Buckanovich, an OCRA grantee, uses a metaphor to describe his work. “If I’m trying to get into Chicago and the highways that get me into the city are blocked off, no matter how important my job is, I’m not going to get there.” He’s talking about immunotherapy and the fact that the cells … Continued
Are you an ovarian cancer survivor, patient, or caregiver? Don’t miss YOUR chance to learn what’s new in ovarian cancer treatments and research, and to meet others in the ovarian cancer community. Early Bird Registration is open! OCRA’s Ovarian Cancer National Conference® brings together people from across the country for a weekend of informative presentations, … Continued
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP inhibitors for ovarian cancer: olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). In an interview with OncLive, Dr. Robert Coleman, a member of OCRA’s Scientific Advisory … Continued
OCRA is pleased to announce we have earned our tenth consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator. We’re proud to again receive this rating, because it reflects our deep commitment to finding a cure for ovarian cancer, investing heavily in discovering new treatments, and hastening breakthroughs to fight this disease. A … Continued
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, along with our other ongoing grants and programs, OCRA is investing nearly $9 million in the fight against ovarian cancer. These grants, awarded internationally for … Continued
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and her colleagues at the University of Pennsylvania successfully created patient “avatars,” which mimic a patient’s biological profile based on a number of factors. Using these … Continued
WASHINGTON, D.C. – December 20, 2019 – Later today, President Trump is expected to sign into law a spending package that funds the government for the remainder of Fiscal Year (FY) 2020 and includes a significant increase in funding for the Ovarian Cancer Research Program (OCRP) at the Department of Defense (DoD). The legislation funds … Continued
(December 19, 2019) A cancer diagnosis can bring with it a bevy of complicated responses, including fear, anger, and even guilt. No one should have to navigate these tricky waters alone. Every day, OCRA’s Woman to Woman peer support programs across the country help hundreds of women diagnosed with gynecologic cancer receive the emotional support … Continued
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives. Our grantees have made incredible progress toward better understanding and eradicating ovarian cancer. Their findings will have real-life impact for women and families battling this disease — and these stunning advancements would … Continued
Get email updates about research news, action alerts, and ways to join the fight.
